“…It has been postulated that the synthesis of 1,25(OH)2D is tightly regulated, and that increases in 25(OH)D concentrations due to exposure to sunlight have no effect on serum 1,25(OH)2D levels (6,82 Cutaneous production of 1,25(OH)2D3 may regulate growth, differentiation, apoptosis and other biological processes in the skin (87,88). Therefore, topical vitamin D analogs have been used as a safe and effective treatment for psoriasis vulgaris (89,90). The NBUVB has been shown to have less capacity to induce a local skin production of 1,25(OH)2D3 at 44% of the monochromatic irradiation at 300 ±2.5 nm (68).…”